Science Current Events | Science News | Brightsurf.com
 

Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC

April 04, 2012

CHICAGO - Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. The findings were presented here at the AACR Annual Meeting 2012, held March 31 - April 4.

"This is a novel immunotherapy that appears to show unusually long survival in some patients," said Lyudmila Bazhenova, M.D., associate clinical professor at the University of California-San Diego Moores Cancer Center in La Jolla, Calif.

These findings represent an updated long-term survival analysis on patients treated with belagenpumatucel-L, a cell-based allogeneic vaccine derived from four lung cancer cell lines. The open-label study included 75 patients with non-small cell lung cancer (NSCLC) - two patients with stage 2 disease, 12 with stage 3A, 15 with stage 3B and 46 with stage 4. The researchers randomly assigned patients to three dose cohorts: 1.25, 2.5 or 5 × 107 cells/injection.

For all patients, median survival was 14.5 months, and the five-year survival rate was 20 percent. The 40 patients with stage 3B/4 cancer enrolled in the second and third dose cohorts had a median survival of 15.9 months and a one-year survival rate of 61 percent, a two-year survival rate of 41 percent and a five-year survival rate of 18 percent.

Patients with stage 3B/4 nonprogressive disease after chemotherapy had a median survival of 44.4 months; five-year survival was 50 percent, which is "unheard of for patients with NSCLC," Bazhenova said.

In contrast, patients who progressed after front-line chemotherapy had a median survival rate of 14.1 months and a 9.1 percent five-year survival rate.

Bazhenova said that although these results are intriguing, they must be confirmed in a phase III clinical trial, which is currently under way in eight countries.

American Association for Cancer Research


Related Non-small Cell Lung Cancer Current Events and Non-small Cell Lung Cancer News Articles


Investigational CDK4/6 inhibitor abemaciclib is active against a range of cancer types
The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial.

Preliminary results comparing PD-L1 IHC diagnostic assays in lung cancer released
A pre-competitive consortia of pharmaceutical companies, diagnostic companies, and academic associations, including the International Association for the Study of Lung Cancer (IASLC), announced phase I results of the "BLUEPRINT PD-L1 IHC ASSAY COMPARISON PROJECT" at the Annual Meeting of the American Association for Cancer Research (AACR) on April 19.

Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer (NSCLC) with a type of radiotherapy called stereotactic body radiation therapy (SBRT) is associated with a small but increased risk of death from causes other than cancer.

Plasma genotyping to predict treatment benefit in patients with NSCLC
The benefit of plasma genotyping to predict treatment benefit in patients with non-small-cell lung cancer (NSCLC) is confirmed in three studies presented today at the European Lung Cancer Conference (ELCC) 2016 in Geneva, Switzerland.

New tool mines whole-exome sequencing data to match cancer with best drug
A University of Colorado Cancer study published today in the Journal of the American Medical Informatics Association (JAMIA) describes a new tool that interprets the raw data of whole exome tumor sequencing and then matches the cancer's unique genetics to FDA-approved targeted treatments.

Researchers identify potential targeted therapy for lung cancer using fly model
A drug approved by the Food and Drug Administration (FDA) for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), according to new research from the Icahn School of Medicine at Mount Sinai.

Improving access to clinical trials when biopsies are required
The requirement for tumor tissue specimens and associated analyses in order to participate in clinical trials appears to be a significant barrier to clinical trial enrollment and may delay treatment.

Three hits to fight lung cancer
Although the most common type of lung cancer - non-small cell lung cancer (NSCLC) - has recently seen major treatment advances in some genetic subtypes, other subtypes continue to evade effective treatment.

Non-small cell lung cancers can be sorted in clusters by endocytic changes
In the Age of Personalized Medicine, we've learned that one size doesn't fit all, least of all in cancer. Cancer is a disease of your cells, and sorting out your cancer from all others is a daunting challenge but one that cancer cell biologists are furiously pursuing.

Researchers identify biomarker of early lung cancer that may increase survival
Researchers in Taiwan have identified a biomarker that detects the most common lung cancer in its earliest stage. The discovery could one day change how long lung cancer patients live.
More Non-small Cell Lung Cancer Current Events and Non-small Cell Lung Cancer News Articles

NCCN Guidelines for Patients®: Non-Small Cell Lung Cancer

NCCN Guidelines for Patients®: Non-Small Cell Lung Cancer
by National Comprehensive Cancer Network® (NCCN®) (Author)


[OFFICIAL CURRENT VERSION] From the medical leaders of 27 of the world’s most renowned cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to non-small cell lung cancer. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources about the diagnosis and treatment of lung cancer. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative handbook be your guide! Part 1 – Lung cancer basics: Explains how lung cancer starts and how it spreads Part 2 – Assessing lung nodules: Discusses care...

Non-Small Cell Lung Cancer: Across the Continuum of Care

Non-Small Cell Lung Cancer: Across the Continuum of Care
by Asante Communications, LLC


This Clinical Resource Tool is structured around consensus statements developed by the Non-Small Cell Lung Cancer (NSCLC) Working Group, a panel of oncologists with particular expertise in the multidimensional care of patients with advanced lung cancer. Using a modified Delphi process, the NSCLC Working Group has consolidated published evidence and expert clinical experience on critical issues pertaining to the comprehensive assessment of patients with advanced NSCLC, formulation of appropriate treatment regimens, implementation of maintenance therapy, and therapeutic alliances among pathologists, oncologists, and pulmonologists. The consensus statements and accompanying resources are intended as a practical companion to current guidelines, helping clinicians individualize best-practice...

What You Need to Know About Non-Small Cell Lung Cancer - It's Your Life, Live It!

What You Need to Know About Non-Small Cell Lung Cancer - It's Your Life, Live It!
by Cancer Group Institute


Selecting the right treatment can literally make the difference between life and death. It is important to have the peace-of-mind knowing that you have done everything possible to help fight Non-Small Cell Lung cancer successfully.

The Cancer Group Institute's book explains, in plain English, the definition, types, frequency, risk factors, symptoms, historic and latest effective treatment for Non-Small Cell Lung cancer. We describe surgery, radiation, chemotherapy and immune therapies. We tell you everything you must know to help make the right choices today for a Non-Small Cell Lung cancer problem.

We are honored to inform you that many leading hospitals use our books in their medical library to be used by physicians. They are Harvard University, Columbia, NYU, ...

Being Mortal: Medicine and What Matters in the End

Being Mortal: Medicine and What Matters in the End
by Atul Gawande (Author)



In Being Mortal, bestselling author Atul Gawande tackles the hardest challenge of his profession: how medicine can not only improve life but also the process of its ending

Medicine has triumphed in modern times, transforming birth, injury, and infectious disease from harrowing to manageable. But in the inevitable condition of aging and death, the goals of medicine seem too frequently to run counter to the interest of the human spirit. Nursing homes, preoccupied with safety, pin patients into railed beds and wheelchairs. Hospitals isolate the dying, checking for vital signs long after the goals of cure have become moot. Doctors, committed to extending life, continue to carry out devastating procedures that in the end extend suffering.Gawande, a practicing surgeon, addresses his...

The Guilty (Will Robie series)

The Guilty (Will Robie series)
by David Baldacci (Author)


Will Robie is the government's most professional, disciplined, and lethal assassin. He infiltrates the most hostile countries in the world, defeats our enemies' advanced security measures, and eliminates threats before they ever reach our shores.
But now, his skills have left him. Sent overseas on a critical assignment, he fails, unable to pull the trigger. Absent his talents, Robie is a man without a mission, and without a purpose.
To recover what he has lost, Robie must confront what he has tried to forget for over twenty years: his own past.
THE GUILTY
Will Robie escaped his small Gulf Coast hometown of Cantrell, Mississippi, after high school, severing all personal ties, and never looked back. Not once. Not until the unimaginable occurs. His father, Dan Robie, has been...

Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 9th Edition

Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 9th Edition
by Sharon L. Lewis (Author), Shannon Ruff Dirksen (Author), Margaret McLean Heitkemper (Author), Linda Bucher (Author)


Over the past three decades, more and more nursing educators have turned to Lewis: Medical-Surgical Nursing for its accurate and up-to-date coverage of the latest trends, hot topics, and clinical developments in the field of medical-surgical nursing ― and the new ninth edition is no exception! Written by a dedicated team of expert authors led by Sharon Lewis, Medical-Surgical Nursing, 9th Edition offers the same easy-to-read style that students have come to love, along with the timely and thoroughly accurate content that educators have come to trust. Completely revised and updated content explores patient care in various clinical settings and focuses on key topics such as prioritization, critical thinking, patient safety, and NCLEX® exam preparation. Best of all ― a complete...

2017 Intravenous Medications: A Handbook for Nurses and Health Professionals, 33e

2017 Intravenous Medications: A Handbook for Nurses and Health Professionals, 33e
by Betty L. Gahart RN (Author), Adrienne R. Nazareno PharmD (Author)


Safely and effectively administer more than 400 intravenous drugs with the expert guidance of this #1 IV drug handbook! Now in its 33rd edition, Gahart’s 2017 Intravenous Medications: A Handbook for Nurses and Health Professionals continues to be a trusted resource its accuracy, quick-reference format, and comprehensive coverage of IV drugs. Each drug monograph includes the drug’s generic name, trade name(s), drug category, pH, dosages and dose adjustments, dilution, incompatibilities, rate of administration, actions, indications and uses, contraindications, precautions, drug/lab interactions, side effects, and antidote. It’s all of the information you will need for the safe administration of IV drugs ― nothing more and nothing less.UNIQUE! Annual publication ensures that...

Small Cell Lung Cancer - Treatment Options and Alternative Medicine

Small Cell Lung Cancer - Treatment Options and Alternative Medicine
by Christian Vazquez (Author)


Small Cell Lung Cancer is a full crash course on the topic. We reviewed over 300 of the strongest natural agents that exist for cancer and found only 6 that have conclusive evidence for small cell lung cancer. The biggest problem is not lack of information in the world, it is the lack of time, understanding of the medical data associated with scientific research and to top it off there is so much data in so many directions between the pharmaceutical, people trying to steer you in the wrong way to make a quick dollar, the quacks of the industry and everything else imaginable where at the end of the day the majority of information learned is wrong. Small cell lung cancer is the fastest growing cancer that exist, there is no time to research or postpone making a decision in treatment. It is...

Still Here: A Novel

Still Here: A Novel
by Lara Vapnyar (Author)


A profound and dazzlingly entertaining novel from the writer Louis Menand calls "Jane Austen with a Russian soul"
 
In her warm, absorbing and keenly observed new novel, Lara Vapnyar follows the intertwined lives of four immigrants in New York City as they grapple with love and tumult, the challenges of a new home, and the absurdities of the digital age.
 
Vica, Vadik, Sergey and Regina met in Russia in their school days, but remained in touch and now have very different American lives. Sergey cycles through jobs as an analyst, hoping his idea for an app will finally bring him success. His wife Vica, a medical technician struggling to keep her family afloat, hungers for a better life. Sergey’s former girlfriend Regina, once a famous translator is married to a...

Study Guide for Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 9e (Study Guide for Medical-Surgical Nursing: Assessment & Management of Clinical Problem)

Study Guide for Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 9e (Study Guide for Medical-Surgical Nursing: Assessment & Management of Clinical Problem)
by Sharon L. Lewis RN PhD FAAN (Author), Linda Bucher RN PhD CEN CNE (Author), Shannon Ruff Dirksen RN PhD (Author)


Prepare for success in the classroom! Corresponding to the chapters in the 9th edition of Lewis' market-leading Medical-Surgical Nursing, this study guide offers a complete review of content and a wide range of activities to help you understand key nursing concepts. Alternate item format questions reflect the most current NCLEX test plan. To make studying easier, answers for all exercises are included in the back of the book.A wide variety of clinically relevant exercises and activities includes NCLEX examination-style multiple-choice questions, prioritization and delegation questions, case studies, fill-in-the-blank questions, anatomy and physiology review, critical thinking activities, and more. Answers to all questions are included in the back of the book, giving you immediate...

© 2016 BrightSurf.com